Share Price and Basic Stock Data
Last Updated: December 9, 2025, 7:27 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Tijaria Polypipes Ltd operates in the plastics sector, primarily focusing on pipes and fittings. The company has faced significant revenue challenges in recent years. Reported sales figures have been on a downward trajectory, plummeting from ₹108.57 Cr in March 2014 to a mere ₹13.85 Cr by March 2023. The latest figures indicate a dismal trend, with quarterly sales reflecting just ₹0.11 Cr in March 2024 and a staggering drop to ₹0.00 Cr in subsequent quarters. This sharp decline raises concerns about the company’s operational viability and market demand for its products. The reported revenue slump is a critical aspect for investors to consider, as it suggests underlying issues that may impact future growth and profitability. Moreover, with a market capitalization of ₹18 Cr, Tijaria appears to be struggling to maintain its market position effectively amidst increasing competition and changing industry dynamics.
Profitability and Efficiency Metrics
Profitability metrics for Tijaria Polypipes reflect a concerning trend in operational efficiency. The company has consistently reported negative operating profits, with an operating profit margin (OPM) that stood at a staggering -30.69% for the fiscal year ending in March 2023. The recent quarterly figures continue this trend, with OPMs reaching -81.82% in March 2024. This persistent lack of profitability indicates that Tijaria is not only grappling with declining sales but also facing significant cost management issues. The interest coverage ratio (ICR) of 1.12x suggests that the company is barely able to meet its interest obligations, which is a red flag for potential liquidity problems. Additionally, the return on capital employed (ROCE) has remained negative, indicating that the company is failing to generate adequate returns on its invested capital. This combination of weak profitability and efficiency metrics raises serious questions about Tijaria’s operational strategy and its ability to navigate the competitive landscape.
Balance Sheet Strength and Financial Ratios
The balance sheet of Tijaria Polypipes reveals a precarious financial position. As of March 2025, the company reported reserves of -₹61.79 Cr, indicating a significant erosion of shareholder equity. This, combined with total borrowings of ₹72.40 Cr, highlights a concerning debt situation where liabilities far exceed assets. The negative book value per share of ₹-11.35 further emphasizes the financial strain Tijaria is under, as it suggests that the company’s liabilities surpass its total assets. While the current ratio of 1.66x indicates a short-term liquidity buffer, it may not be sufficient to offset the long-term solvency concerns posed by the high levels of debt. The historical trend of increasing borrowings alongside declining revenues paints a troubling picture of financial health, suggesting that the company might struggle to sustain operations without significant restructuring or a turnaround strategy.
Shareholding Pattern and Investor Confidence
Examining the shareholding pattern of Tijaria Polypipes reveals a complex landscape of investor confidence. Promoters hold 35.27% of the company, which reflects a stable but not overwhelming commitment from those with insider knowledge. The public holds a significant 60.91%, indicating widespread retail interest, but the absence of institutional investors (DIIs) raises questions about the stock’s attractiveness to larger, more risk-averse investors. Foreign institutional investors (FIIs) have a minor stake of 3.84%, which has fluctuated over time, suggesting cautious interest. The increasing number of shareholders, which stood at 11,585, may indicate that retail investors are still willing to buy into the story, despite the underlying financial challenges. However, the high public ownership juxtaposed with minimal institutional backing could lead to volatility, particularly if sentiment shifts due to ongoing operational struggles.
Outlook, Risks, and Final Insight
The outlook for Tijaria Polypipes is fraught with risks that investors must carefully weigh. The ongoing decline in sales, coupled with persistent operational losses, raises doubts about the company’s long-term viability. A potential turnaround would require significant strategic adjustments, possibly including cost-cutting measures, restructuring, or even diversification into more profitable segments. However, with the current financial metrics indicating a strained balance sheet and negative equity, the path to recovery appears steep. Investors should be cautious about entering or holding onto this stock, given the lack of positive momentum and the potential for further declines. The risk of liquidity issues looms large, especially in a competitive market where operational efficiency is paramount. Ultimately, while Tijaria Polypipes may hold some allure for risk-tolerant investors looking for a turnaround story, the substantial financial hurdles present a significant barrier to achieving sustainable growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Tijaria Polypipes Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dutron Polymers Ltd | 67.4 Cr. | 112 | 175/107 | 32.1 | 49.1 | 1.34 % | 12.3 % | 9.68 % | 10.0 |
| Captain Polyplast Ltd | 477 Cr. | 79.5 | 128/58.4 | 24.1 | 28.0 | 0.00 % | 16.1 % | 15.0 % | 2.00 |
| Captain Pipes Ltd | 182 Cr. | 11.8 | 21.0/11.7 | 51.1 | 2.69 | 0.00 % | 17.0 % | 13.5 % | 1.00 |
| Caprihans India Ltd | 122 Cr. | 83.5 | 184/78.1 | 269 | 0.00 % | 0.78 % | 18.9 % | 10.0 | |
| Ashish Polyplast Ltd | 10.5 Cr. | 31.0 | 63.7/30.0 | 20.7 | 0.00 % | 5.09 % | 2.58 % | 10.0 | |
| Industry Average | 5,508.25 Cr | 198.15 | 46.50 | 86.74 | 0.24% | 10.40% | 10.62% | 8.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.91 | 0.09 | 0.00 | 3.84 | 0.04 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 11.53 | 0.43 | 0.29 | 5.86 | 0.23 | 0.01 | 0.03 | 0.20 | 0.17 | 0.04 | 0.04 | 0.05 | 0.10 |
| Operating Profit | -1.62 | -0.34 | -0.29 | -2.02 | -0.19 | -0.01 | -0.03 | -0.09 | -0.17 | -0.04 | -0.04 | -0.05 | -0.10 |
| OPM % | -16.35% | -377.78% | -52.60% | -475.00% | -81.82% | ||||||||
| Other Income | 0.06 | 0.03 | 0.03 | 0.04 | 0.02 | 0.04 | 0.03 | 0.08 | 0.13 | 0.05 | 0.06 | -3.06 | 0.02 |
| Interest | 1.96 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.85 | 0.83 | 0.83 | 0.80 | 0.68 | 0.69 | 0.69 | 0.70 | 0.58 | 0.94 | 0.76 | 0.03 | 0.19 |
| Profit before tax | -4.37 | -1.17 | -1.10 | -2.79 | -0.85 | -0.66 | -0.69 | -0.71 | -0.62 | -0.93 | -0.74 | -3.14 | -0.27 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -4.37 | -1.17 | -1.11 | -2.80 | -0.85 | -0.66 | -0.69 | -0.71 | -0.62 | -0.93 | -0.74 | -3.14 | -0.27 |
| EPS in Rs | -1.53 | -0.41 | -0.39 | -0.98 | -0.30 | -0.23 | -0.24 | -0.25 | -0.22 | -0.32 | -0.26 | -1.10 | -0.09 |
Last Updated: August 20, 2025, 2:15 am
Below is a detailed analysis of the quarterly data for Tijaria Polypipes Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.05 Cr. (Mar 2025) to 0.10 Cr., marking an increase of 0.05 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.10 Cr.. The value appears to be declining and may need further review. It has decreased from -0.05 Cr. (Mar 2025) to -0.10 Cr., marking a decrease of 0.05 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 0.02 Cr.. The value appears strong and on an upward trend. It has increased from -3.06 Cr. (Mar 2025) to 0.02 Cr., marking an increase of 3.08 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.03 Cr. (Mar 2025) to 0.19 Cr., marking an increase of 0.16 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.27 Cr.. The value appears strong and on an upward trend. It has increased from -3.14 Cr. (Mar 2025) to -0.27 Cr., marking an increase of 2.87 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.27 Cr.. The value appears strong and on an upward trend. It has increased from -3.14 Cr. (Mar 2025) to -0.27 Cr., marking an increase of 2.87 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.09. The value appears strong and on an upward trend. It has increased from -1.10 (Mar 2025) to -0.09, marking an increase of 1.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:16 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 108.57 | 69.11 | 87.03 | 63.54 | 76.34 | 149.53 | 73.39 | 62.46 | 54.88 | 13.85 | 0.15 | -0.00 | 0.00 |
| Expenses | 99.49 | 61.05 | 80.92 | 66.07 | 83.95 | 129.73 | 64.62 | 66.11 | 63.93 | 18.10 | 0.45 | 0.27 | 0.23 |
| Operating Profit | 9.08 | 8.06 | 6.11 | -2.53 | -7.61 | 19.80 | 8.77 | -3.65 | -9.05 | -4.25 | -0.30 | -0.27 | -0.23 |
| OPM % | 8.36% | 11.66% | 7.02% | -3.98% | -9.97% | 13.24% | 11.95% | -5.84% | -16.49% | -30.69% | -200.00% | ||
| Other Income | -0.00 | 5.05 | 0.19 | -1.42 | -1.06 | 0.67 | 0.36 | 0.91 | -0.11 | 0.13 | 0.17 | -2.83 | -2.93 |
| Interest | 8.85 | 8.73 | 9.10 | 7.18 | 7.51 | 7.94 | 6.40 | 6.51 | 8.42 | 2.01 | 0.02 | 0.02 | 0.00 |
| Depreciation | 10.43 | 13.53 | 11.80 | 9.78 | 8.23 | 6.34 | 5.20 | 4.76 | 4.13 | 3.32 | 2.76 | 2.31 | 1.92 |
| Profit before tax | -10.20 | -9.15 | -14.60 | -20.91 | -24.41 | 6.19 | -2.47 | -14.01 | -21.71 | -9.45 | -2.91 | -5.43 | -5.08 |
| Tax % | 5.98% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | |
| Net Profit | -10.80 | -9.15 | -14.60 | -20.92 | -24.41 | 6.19 | -2.46 | -14.01 | -21.70 | -9.46 | -2.92 | -5.43 | -5.08 |
| EPS in Rs | -4.57 | -3.87 | -6.18 | -8.85 | -10.33 | 2.32 | -0.86 | -4.89 | -7.58 | -3.30 | -1.02 | -1.90 | -1.77 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 15.28% | -59.56% | -43.29% | -16.68% | 125.36% | -139.74% | -469.51% | -54.89% | 56.41% | 69.13% | -85.96% |
| Change in YoY Net Profit Growth (%) | 0.00% | -74.84% | 16.28% | 26.61% | 142.04% | -265.10% | -329.77% | 414.62% | 111.29% | 12.73% | -155.09% |
Tijaria Polypipes Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 1% |
| 3 Years: | 24% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 3% |
| 3 Years: | 14% |
| 1 Year: | -52% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: December 4, 2025, 2:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23.63 | 23.63 | 23.63 | 23.63 | 23.63 | 26.72 | 28.63 | 28.63 | 28.63 | 28.63 | 28.63 | 28.63 | 28.63 |
| Reserves | 55.50 | 46.31 | 31.71 | 10.79 | -11.84 | -5.37 | -7.73 | -21.66 | -43.35 | -52.78 | -55.70 | -61.13 | -61.79 |
| Borrowings | 65.58 | 62.07 | 64.63 | 67.23 | 69.90 | 54.12 | 50.76 | 65.88 | 69.15 | 76.36 | 72.41 | 77.40 | 72.40 |
| Other Liabilities | 10.00 | 13.54 | 10.87 | 13.36 | 30.23 | 35.10 | 24.14 | 24.02 | 13.27 | 9.32 | 9.18 | 9.58 | 9.84 |
| Total Liabilities | 154.71 | 145.55 | 130.84 | 115.01 | 111.92 | 110.57 | 95.80 | 96.87 | 67.70 | 61.53 | 54.52 | 54.48 | 49.08 |
| Fixed Assets | 90.33 | 75.67 | 65.41 | 57.71 | 47.13 | 39.19 | 34.52 | 33.56 | 28.79 | 25.31 | 22.55 | 17.12 | 16.74 |
| CWIP | 7.03 | 1.25 | 1.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 57.35 | 68.63 | 64.07 | 57.30 | 64.79 | 71.38 | 61.28 | 63.18 | 38.91 | 36.22 | 31.97 | 37.36 | 32.34 |
| Total Assets | 154.71 | 145.55 | 130.84 | 115.01 | 111.92 | 110.57 | 95.80 | 96.87 | 67.70 | 61.53 | 54.52 | 54.48 | 49.08 |
Below is a detailed analysis of the balance sheet data for Tijaria Polypipes Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 28.63 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 28.63 Cr..
- For Reserves, as of Sep 2025, the value is -61.79 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -61.13 Cr. (Mar 2025) to -61.79 Cr., marking a decline of 0.66 Cr..
- For Borrowings, as of Sep 2025, the value is 72.40 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 77.40 Cr. (Mar 2025) to 72.40 Cr., marking a decrease of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 9.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.58 Cr. (Mar 2025) to 9.84 Cr., marking an increase of 0.26 Cr..
- For Total Liabilities, as of Sep 2025, the value is 49.08 Cr.. The value appears to be improving (decreasing). It has decreased from 54.48 Cr. (Mar 2025) to 49.08 Cr., marking a decrease of 5.40 Cr..
- For Fixed Assets, as of Sep 2025, the value is 16.74 Cr.. The value appears to be declining and may need further review. It has decreased from 17.12 Cr. (Mar 2025) to 16.74 Cr., marking a decrease of 0.38 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 32.34 Cr.. The value appears to be declining and may need further review. It has decreased from 37.36 Cr. (Mar 2025) to 32.34 Cr., marking a decrease of 5.02 Cr..
- For Total Assets, as of Sep 2025, the value is 49.08 Cr.. The value appears to be declining and may need further review. It has decreased from 54.48 Cr. (Mar 2025) to 49.08 Cr., marking a decrease of 5.40 Cr..
However, the Borrowings (72.40 Cr.) are higher than the Reserves (-61.79 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -56.50 | -54.01 | -58.52 | -69.76 | -77.51 | -34.32 | -41.99 | -69.53 | -78.20 | -80.61 | -72.71 | -77.67 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 93.70 | 167.26 | 103.97 | 152.86 | 163.47 | 136.04 | 198.19 | 218.50 | 167.67 | 659.90 | 60,784.67 | |
| Inventory Days | 71.18 | 190.53 | 168.43 | 147.34 | 85.65 | 29.43 | 100.16 | 109.28 | 39.39 | 11.91 | 997.67 | |
| Days Payable | 31.01 | 85.09 | 46.37 | 71.98 | 161.85 | 116.40 | 175.15 | 114.50 | 72.58 | 167.97 | 16,863.00 | |
| Cash Conversion Cycle | 133.86 | 272.71 | 226.03 | 228.22 | 87.27 | 49.07 | 123.19 | 213.27 | 134.49 | 503.84 | 44,919.33 | |
| Working Capital Days | 13.72 | 67.66 | 15.81 | 57.79 | -31.08 | 34.20 | 80.12 | 153.69 | 67.91 | 324.15 | 30,343.67 | |
| ROCE % | -0.90% | -3.35% | -4.29% | -10.73% | -16.85% | 18.22% | 5.36% | -10.44% | -20.41% | -13.88% | -5.88% | -5.05% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -2.30 | -1.23 | -3.30 | -7.57 | -4.87 |
| Diluted EPS (Rs.) | -2.30 | -1.23 | -3.30 | -7.57 | -4.87 |
| Cash EPS (Rs.) | -1.09 | -0.05 | -2.60 | -6.14 | -3.23 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -11.35 | -9.46 | -8.44 | -5.14 | 2.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -11.35 | -9.46 | -8.44 | -5.14 | 2.43 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.05 | 4.84 | 19.17 | 21.82 |
| PBDIT / Share (Rs.) | 0.01 | -0.04 | -1.44 | -3.20 | -1.56 |
| PBIT / Share (Rs.) | -0.79 | -1.01 | -2.14 | -4.64 | -3.23 |
| PBT / Share (Rs.) | -0.80 | -1.02 | -3.30 | -7.58 | -4.89 |
| Net Profit / Share (Rs.) | -1.90 | -1.02 | -3.30 | -7.58 | -4.89 |
| PBDIT Margin (%) | 0.00 | -79.03 | -29.67 | -16.67 | -7.16 |
| PBIT Margin (%) | 0.00 | -1940.33 | -44.21 | -24.20 | -14.79 |
| PBT Margin (%) | 0.00 | -1963.75 | -68.28 | -39.54 | -22.43 |
| Net Profit Margin (%) | 0.00 | -1963.75 | -68.28 | -39.54 | -22.43 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | 0.00 | -201.27 |
| Return on Capital Employeed (%) | -6.91 | -7.50 | -14.82 | -30.52 | -13.83 |
| Return On Assets (%) | -9.96 | -5.34 | -15.36 | -32.05 | -14.46 |
| Long Term Debt / Equity (X) | -2.02 | -2.42 | -2.71 | -3.96 | 8.60 |
| Total Debt / Equity (X) | -2.38 | -2.67 | -3.16 | -4.70 | 9.46 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.21 | 0.66 | 0.64 |
| Current Ratio (X) | 1.66 | 1.88 | 1.71 | 1.54 | 2.04 |
| Quick Ratio (X) | 1.64 | 1.86 | 1.69 | 1.30 | 1.55 |
| Inventory Turnover Ratio (X) | 0.00 | 0.10 | 3.43 | 4.94 | 3.54 |
| Interest Coverage Ratio (X) | 1.12 | -6.99 | -1.24 | -1.09 | -0.93 |
| Interest Coverage Ratio (Post Tax) (X) | -128.14 | -171.73 | -1.84 | -1.58 | -1.94 |
| Enterprise Value (Cr.) | 91.12 | 107.14 | 84.52 | 84.89 | 78.81 |
| EV / Net Operating Revenue (X) | 0.00 | 721.44 | 6.10 | 1.55 | 1.26 |
| EV / EBITDA (X) | 4578.83 | -912.86 | -20.57 | -9.27 | -17.60 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 245.76 | 0.90 | 0.33 | 0.28 |
| Price / BV (X) | -0.47 | -1.35 | -0.52 | -1.25 | 2.59 |
| Price / Net Operating Revenue (X) | 0.00 | 250.00 | 0.90 | 0.33 | 0.28 |
| EarningsYield | -0.34 | -0.07 | -0.75 | -1.18 | -0.77 |
After reviewing the key financial ratios for Tijaria Polypipes Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -2.30. This value is below the healthy minimum of 5. It has decreased from -1.23 (Mar 24) to -2.30, marking a decrease of 1.07.
- For Diluted EPS (Rs.), as of Mar 25, the value is -2.30. This value is below the healthy minimum of 5. It has decreased from -1.23 (Mar 24) to -2.30, marking a decrease of 1.07.
- For Cash EPS (Rs.), as of Mar 25, the value is -1.09. This value is below the healthy minimum of 3. It has decreased from -0.05 (Mar 24) to -1.09, marking a decrease of 1.04.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -11.35. It has decreased from -9.46 (Mar 24) to -11.35, marking a decrease of 1.89.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -11.35. It has decreased from -9.46 (Mar 24) to -11.35, marking a decrease of 1.89.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 2. It has increased from -0.04 (Mar 24) to 0.01, marking an increase of 0.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.79. This value is below the healthy minimum of 0. It has increased from -1.01 (Mar 24) to -0.79, marking an increase of 0.22.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.80. This value is below the healthy minimum of 0. It has increased from -1.02 (Mar 24) to -0.80, marking an increase of 0.22.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.90. This value is below the healthy minimum of 2. It has decreased from -1.02 (Mar 24) to -1.90, marking a decrease of 0.88.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -79.03 (Mar 24) to 0.00, marking an increase of 79.03.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -1,940.33 (Mar 24) to 0.00, marking an increase of 1,940.33.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -1,963.75 (Mar 24) to 0.00, marking an increase of 1,963.75.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -1,963.75 (Mar 24) to 0.00, marking an increase of 1,963.75.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -6.91. This value is below the healthy minimum of 10. It has increased from -7.50 (Mar 24) to -6.91, marking an increase of 0.59.
- For Return On Assets (%), as of Mar 25, the value is -9.96. This value is below the healthy minimum of 5. It has decreased from -5.34 (Mar 24) to -9.96, marking a decrease of 4.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -2.02. This value is below the healthy minimum of 0.2. It has increased from -2.42 (Mar 24) to -2.02, marking an increase of 0.40.
- For Total Debt / Equity (X), as of Mar 25, the value is -2.38. This value is within the healthy range. It has increased from -2.67 (Mar 24) to -2.38, marking an increase of 0.29.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Current Ratio (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 1.88 (Mar 24) to 1.66, marking a decrease of 0.22.
- For Quick Ratio (X), as of Mar 25, the value is 1.64. This value is within the healthy range. It has decreased from 1.86 (Mar 24) to 1.64, marking a decrease of 0.22.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 0.10 (Mar 24) to 0.00, marking a decrease of 0.10.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 3. It has increased from -6.99 (Mar 24) to 1.12, marking an increase of 8.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -128.14. This value is below the healthy minimum of 3. It has increased from -171.73 (Mar 24) to -128.14, marking an increase of 43.59.
- For Enterprise Value (Cr.), as of Mar 25, the value is 91.12. It has decreased from 107.14 (Mar 24) to 91.12, marking a decrease of 16.02.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 721.44 (Mar 24) to 0.00, marking a decrease of 721.44.
- For EV / EBITDA (X), as of Mar 25, the value is 4,578.83. This value exceeds the healthy maximum of 15. It has increased from -912.86 (Mar 24) to 4,578.83, marking an increase of 5,491.69.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 245.76 (Mar 24) to 0.00, marking a decrease of 245.76.
- For Price / BV (X), as of Mar 25, the value is -0.47. This value is below the healthy minimum of 1. It has increased from -1.35 (Mar 24) to -0.47, marking an increase of 0.88.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 250.00 (Mar 24) to 0.00, marking a decrease of 250.00.
- For EarningsYield, as of Mar 25, the value is -0.34. This value is below the healthy minimum of 5. It has decreased from -0.07 (Mar 24) to -0.34, marking a decrease of 0.27.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Tijaria Polypipes Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -6.91% (Industry Average ROCE: 10.4%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 10.62%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -128.14
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.64
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 46.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -2.38
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
Fundamental Analysis of Tijaria Polypipes Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Pipes & Fittings | SP-1-2316, RIICO Industries Area, Jaipur Rajasthan 302022 | investors@tijaria-pipes.com http://www.tijaria-pipes.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Alok Jain Tijaria | Managing Director |
| Mr. Vikas Jain Tijaria | Whole Time Director - Marketing |
| Mr. Praveen Jain Tijaria | Whole Time Director |
| Mr. Vineet Jain Tijaria | Whole Time Director - Finance |
| Ms. Khushi Nagrath | Ind. Non-Executive Woman Director |
| Mr. Vinod Patni | Ind. Non-Executive Director |
| Mr. Ravi Prakash Jain | Ind. Non-Executive Director |
| Mrs. Sonu Surana | Ind. Non-Executive Woman Director |
Tijaria Polypipes Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹28.01 |
| Previous Day | ₹27.47 |
FAQ
What is the intrinsic value of Tijaria Polypipes Ltd?
Tijaria Polypipes Ltd's intrinsic value (as of 09 December 2025) is 21.30 which is 229.72% higher the current market price of 6.46, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 18.5 Cr. market cap, FY2025-2026 high/low of 14.2/4.88, reserves of ₹-61.79 Cr, and liabilities of 49.08 Cr.
What is the Market Cap of Tijaria Polypipes Ltd?
The Market Cap of Tijaria Polypipes Ltd is 18.5 Cr..
What is the current Stock Price of Tijaria Polypipes Ltd as on 09 December 2025?
The current stock price of Tijaria Polypipes Ltd as on 09 December 2025 is 6.46.
What is the High / Low of Tijaria Polypipes Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Tijaria Polypipes Ltd stocks is 14.2/4.88.
What is the Stock P/E of Tijaria Polypipes Ltd?
The Stock P/E of Tijaria Polypipes Ltd is .
What is the Book Value of Tijaria Polypipes Ltd?
The Book Value of Tijaria Polypipes Ltd is 11.6.
What is the Dividend Yield of Tijaria Polypipes Ltd?
The Dividend Yield of Tijaria Polypipes Ltd is 0.00 %.
What is the ROCE of Tijaria Polypipes Ltd?
The ROCE of Tijaria Polypipes Ltd is 5.05 %.
What is the ROE of Tijaria Polypipes Ltd?
The ROE of Tijaria Polypipes Ltd is %.
What is the Face Value of Tijaria Polypipes Ltd?
The Face Value of Tijaria Polypipes Ltd is 10.0.